Chen, Tom Wei-Wu
Jan, I-Shiow
Chang, Dwang-Ying
Lin, Ching-Hung
Chen, I-Chun
Chen, Ho-Min
Cheng, Ann-Lii
Lu, Yen-Shen http://orcid.org/0000-0001-7461-1291
Article History
Received: 10 March 2020
Accepted: 18 April 2020
First Online: 29 April 2020
Compliance with ethical standards
:
: TWC reports personal fees from Roche for honorarium. YSL reports clinical trial study fee from Novartis, Roche, Merck Sharp & Dohme, Pfizer, and GlaxoSmithKline; personal fees from Novartis, Pfizer, Boehringer Ingelheim, and Eisai for consultant fee and honorarium. ALC reports clinical trial study fee and honorarium from Roche. All other authors have no conflict of interest.
: The NTUH Research Ethics Committee approved the study under a blanket protocol (201003025R) for analysis of medical data from patients with stage IV breast cancer. Informed consent from the patients was waived for retrospective medical record review studies per the protocol of the NTUH Research Ethics Committee.